Marc Bardou

25PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersHealth equityMajor global burdens of diseaseMolecular medicineCultural studies of nation and region
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 02, 2026
Reply to "Preclinical and Clinical Evidence on Chloroquine or Hydroxychloroquine in COVID-19": Achieving Statistical Significance Does Not Mean That Clinical Relevance Can Be Disregarded, and This Must Be Considered When Interpreting Results.

|Mar 25, 2026
Health equity under siege: the populist challenge to women's health in Europe.

Rachel Greenley, Anneli Uusküla, Pia Kirkegaard

|Mar 02, 2026
Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.

Amir Hassine, Anna Tisler, Myriam Martel

|Feb 16, 2026
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Inès Ben Ghezala, Nathan Peiffer-Smadja, Caroline Solas

|Jan 25, 2025
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.

Rikke Buus Bøje, Marc Bardou, Keitly Mensah

|Jan 14, 2025
A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM study protocol.

Maxime Luu, Pierre Vabres, Aurélie Espitalier

Pageof 5

Frequent Collaborators

4 joint publications

Alan N Barkun

4 joint publications

Maxime Luu

4 joint publications

Inès Ben Ghezala

3 joint publications

Anneli Uusküla